ICR WHITE PAPER 010
FROM FRAMEWORK TO EVIDENCE
A Methodological Bridge From Conceptual Framework to Testable Evidence
David FischerInstitute for Coherence and Regulation (ICR)Knightdale, North Carolina, USASeptember 2026 | Publication Version 1.0
Recommended citationFischer, D. (2026). From Framework to Evidence: A Methodological Bridge From Conceptual Framework to Testable Evidence. ICR White Paper 010 (Publication Version 1.0). Institute for Coherence and Regulation.
DOI: 10.5281/zenodo.22710419
Abstract
The Coherence & Regulation Framework (CRF) is intended to generate testable propositions rather than function as a self-validating belief system. This white paper establishes the Institute for Coherence and Regulation Research and Validation Standard: a governance framework specifying how conceptual propositions, measures, wellness-program observations, case reports, observational studies, controlled studies, mechanism studies, and replications should alter ICR's confidence and public claims. The standard is built around scientific rigor, transparency, prospective specification, appropriate reporting guidelines, reproducibility, measurement validity, competing explanations, adverse-event reporting, conflict-of-interest disclosure, and publication of null or contradictory findings. It distinguishes exploratory work from confirmatory evidence and explicitly prohibits treating uncontrolled improvement, testimonials, practitioner observation, proprietary scores, or inclusion in the CRF as proof of efficacy or mechanism. Evidence is organized into six levels from conceptual formulation through independent replication and synthesis. Advancement requires predefined criteria; downgrade is mandatory when stronger evidence contradicts earlier claims. The standard is intended to govern future ICR research, publications, courses, practitioner materials, websites, and public communication.
Keywords: research standard; validation; evidence hierarchy; reproducibility; preregistration; case study; observational research; controlled trial; reporting guidelines; scientific integrity
1. Purpose
The credibility of an emerging framework depends less on the number of favorable observations it collects than on the rules it uses when observations are ambiguous, null, or contradictory. ICR therefore requires an explicit standard for moving from an idea to evidence.
This document governs scientific and quasi-scientific claims made under the ICR name. It applies to CRF concepts, outcome measures, Structured Rest, educational programs, practitioner approaches, wellness modalities studied by ICR, and future coherence or reserve instruments.
The standard does not convert ICR into a medical research institution or authorize activities requiring licensure, institutional oversight, regulatory approval, or clinical expertise.
2. Governing Principle
ICR will claim no more than the strongest reproducible evidence directly supports.
The Institute will distinguish what is observed from what is inferred; what is associated from what is causal; what is plausible from what is demonstrated; what is internally observed from what is independently replicated; and wellness outcomes from medical outcomes.
A framework proposition does not become true because it is internally consistent. It must survive attempts to measure, challenge, compare, and falsify it.
3. Scientific Rigor
The National Institutes of Health defines scientific rigor as strict application of the scientific method to support unbiased and well-controlled design, methodology, analysis, interpretation, and reporting. ICR adopts that general principle.
Rigor does not mean every early project must be a randomized controlled trial. It means each design is used for questions it can legitimately answer, its limitations are stated, and claims do not exceed the design.
A carefully reported case series can be useful for feasibility and hypothesis generation. It cannot establish efficacy.
4. The ICR Evidence Ladder
Level
Designation
Typical evidence
What it can support
What it cannot support
0
Conceptual
Framework, rationale, literature synthesis
Definitions, hypotheses, research agenda
Efficacy, mechanism, diagnosis
1
Feasibility / Descriptive
Case reports, case series, pilot process data
Feasibility, acceptability, observations, signal detection
Causal efficacy
2
Associational
Cross-sectional or longitudinal observational data
Association, prediction, trajectories
Uncontrolled causal claims
3
Comparative
Controlled nonrandomized or randomized studies
Comparative effect under defined conditions
Universal effectiveness or mechanism
4
Mechanistic / Measurement Validation
Direct mechanism tests, validated instruments, mediation where justified
Specific measured mechanism or construct validity
Unmeasured mechanisms
5
Independent Replication
External teams reproduce findings
Generalizability and stronger confidence
Absolute certainty
6
Synthesis / Convergence
Multiple independent studies, systematic review/meta-analysis where appropriate
Mature evidence statement and bounded practice implications
Claims beyond included populations/interventions
5. Evidence Level Does Not Equal Study Prestige
The ladder describes what type of inference evidence can support. A poorly executed randomized trial can provide weaker evidence than a rigorous prospective observational study for some questions. Likewise, a mechanism experiment may establish a pathway without demonstrating meaningful real-world benefit.
Quality, bias, measurement validity, precision, reproducibility, applicability, and consistency must be considered alongside design.
ICR will therefore record both evidence level and evidence quality.
6. Exploratory Versus Confirmatory Work
Exploratory research asks what patterns may exist. Confirmatory research tests a prespecified hypothesis using a prespecified analysis and outcome.
Exploration is legitimate and necessary. The problem occurs when exploratory findings are reported as though they were predicted in advance.
ICR publications must label analyses as exploratory or confirmatory. Post hoc hypotheses may generate future studies but will not be rewritten as prior predictions.
7. Protocol Before Outcome
Whenever practical, prospective studies should create a dated protocol before outcome analysis. The protocol should identify the question, population, intervention/exposure, comparator when applicable, primary and secondary outcomes, timing, exclusion criteria, adverse-event procedures, analysis plan, and stopping rules.
For stronger confirmatory work, ICR should use a public preregistration or registered protocol when appropriate. Protocol deviations should be documented rather than silently corrected after results are known.
The purpose is not bureaucracy. It is to separate what investigators intended to test from what they discovered while looking at the data.
8. Reporting Guidelines
ICR will use established reporting guidelines appropriate to study design. The EQUATOR Network maintains a comprehensive library and identifies major standards including CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews, SPIRIT for trial protocols, STARD for diagnostic accuracy, TRIPOD for prediction models, CARE for case reports, and SQUIRE for quality-improvement studies.
Use of a checklist does not make a study rigorous by itself. It improves transparency by making essential information harder to omit.
ICR study type
Preferred reporting framework
ICR use
Individual case report
CARE
Detailed descriptive report; no efficacy claim
Case series
CARE principles plus appropriate case-series guidance
Feasibility and signal generation
Observational cohort/cross-sectional
STROBE
Associations and trajectories
Randomized trial
CONSORT
Comparative effect
Trial protocol
SPIRIT
Prospective transparency
Systematic review
PRISMA
Evidence synthesis
Prediction model
TRIPOD
Model development/validation
Measurement-property study
COSMIN-aligned guidance
Instrument reliability/validity
Quality improvement
SQUIRE
Operational improvement rather than efficacy
9. Case Reports and Testimonials
Case reports document what happened to an individual. Testimonials document what a person says happened. Both can identify questions, implementation issues, unexpected experiences, or outcomes worth studying.
Neither can determine whether the intervention caused the outcome. Alternative explanations include natural history, regression to the mean, concurrent care, behavior change, expectation, attention, reporting bias, and measurement variability.
Testimonials used for marketing must never be presented as scientific validation. Research consent and testimonial-publication consent should remain distinct.
10. ICR Case Series Standard
Define the evaluation purpose before enrollment.
Use consistent inclusion and exclusion criteria.
Use the same core outcome schedule for all participants when feasible.
Record concurrent therapies and major behavioral changes.
Record missed sessions, deviations, withdrawals, and adverse experiences.
Report every enrolled participant or explain exclusions.
Do not publish only favorable participants.
Separate participant-reported outcomes from practitioner observations.
Do not infer mechanisms that were not measured.
Describe results as preliminary, exploratory, or feasibility evidence.
11. Outcome Selection
Primary outcomes should be selected because they answer the research question, not because they are likely to improve. Validated instruments are preferred when suitable.
Institute-created 0–10 ratings can be useful for exploratory tracking but remain exploratory until their reliability, validity, responsiveness, and interpretation are established.
Multiple outcomes create a risk of finding a favorable result by chance. Confirmatory studies should identify a limited number of primary outcomes in advance and address multiplicity where appropriate.
12. Measurement Validity
A construct can only be tested through measures that adequately represent it. WP-009 therefore prohibits treating an unvalidated score as proof of coherence.
Measurement studies should evaluate reliability, measurement error, content validity, structural validity when relevant, convergent and discriminant validity, responsiveness, and interpretability.
If a measure changes but the meaning of that change is unknown, ICR should report the numerical change without labeling it clinically or biologically meaningful.
13. Mechanism Claims
Mechanism claims require mechanism-level measurement. A participant feeling calmer does not establish vagal activation, cortisol normalization, reduced inflammation, improved mitochondrial function, cellular repair, detoxification, or immune modulation.
A mechanism study must define the pathway, measure relevant variables at appropriate times, address plausible confounders, and ideally demonstrate that the mechanism explains part of the observed effect.
Mechanistic plausibility from unrelated literature is not equivalent to demonstrating that an ICR intervention operates through that mechanism.
14. Comparator Selection
The comparator determines what question a comparative study answers. A wait-list comparison can estimate benefit relative to waiting but cannot isolate attention or expectancy. An attention control can address some nonspecific effects. An active comparator can ask whether one approach performs differently from another.
For Structured Rest, useful comparators may include usual break behavior, screen-based break activity, quiet sitting, or another standardized low-demand condition depending on the hypothesis.
ICR should not describe a study as controlled unless the comparator is defined and prospectively applied.
15. Randomization and Blinding
Randomization reduces systematic allocation differences when implemented correctly. Blinding can reduce expectancy, observer, and analytic bias, although full participant or practitioner blinding may be impossible for many behavioral or wellness interventions.
When blinding is impossible, ICR should strengthen other protections: standardized scripts, blinded outcome assessment where feasible, objective outcomes, prespecified analysis, and transparent disclosure.
Imperfect blinding is a limitation, not permission to ignore bias.
16. Sample Size
Sample size should match the question. Small pilot studies can estimate feasibility, recruitment, adherence, variance, and protocol problems. They generally cannot provide stable efficacy estimates or support complex multivariable models.
Confirmatory studies should justify sample size prospectively based on the primary outcome, expected effect or precision target, statistical model, attrition, and multiplicity where relevant.
ICR will not characterize a statistically significant result from a very small exploratory study as definitive evidence.
17. Statistical Analysis
Specify primary analyses before examining outcomes when confirmatory.
Report effect sizes and uncertainty, not only p-values.
Use confidence intervals where appropriate.
Report absolute numbers as well as percentages when useful.
Address missing data transparently.
Do not remove outliers solely because they weaken the result.
Distinguish within-person from between-person inference.
Account for repeated measurements appropriately.
Control model complexity relative to sample size.
Use sensitivity analyses when assumptions materially affect conclusions.
18. Statistical Significance Is Not Practical Importance
A small difference can be statistically detectable but practically trivial. A large apparent difference can be too imprecise to support confidence.
ICR should emphasize magnitude, uncertainty, consistency, functional relevance, participant burden, harms, and reproducibility.
The phrase 'significant improvement' should specify whether significance is statistical, clinically meaningful, practically meaningful, or simply noticeable to participants.
19. Adverse Events and Unfavorable Outcomes
Scientific credibility requires documenting unfavorable outcomes with the same seriousness as favorable ones. ICR studies should prospectively define what constitutes an adverse event or adverse experience appropriate to the intervention.
Reports should include withdrawals, symptom worsening, discomfort, device intolerance, falls, dizziness, anxiety, sleep disruption, or other relevant events rather than discussing benefits alone.
A low-risk wellness designation does not eliminate the obligation to monitor and report harms.
20. Safety Escalation
Research and wellness participation must never delay appropriate medical care. Protocols should identify symptoms or circumstances requiring discontinuation and referral or emergency evaluation.
Device-specific contraindications, manufacturer instructions, licensure boundaries, and applicable law remain separate from this scientific evidence standard and must be followed independently.
An observed medical concern should not be reinterpreted as a desirable 'healing response' without evidence.
21. Conflict of Interest
ICR and its founder have intellectual and commercial interests in the framework, educational programs, certifications, publications, and wellness services. That relationship must be disclosed in research outputs.
Internal research is legitimate, but independent replication carries greater evidentiary weight because it reduces dependence on the originator's incentives, expectations, procedures, and analytic choices.
When possible, higher-level studies should include independent statistical review, external collaborators, preregistration, or other safeguards.
22. Data Integrity and Auditability
ICR research records should preserve original observations, dates, versions, protocol deviations, consent documentation, analysis files, and a clear audit trail.
Corrections should create a traceable revision rather than silently replacing original values. Identifiable participant information should be protected according to applicable privacy, ethical, and legal requirements.
De-identified analytic datasets and code should be shared when lawful, ethical, and feasible, especially for claims intended to influence the scientific literature.
23. Null, Negative, and Contradictory Results
Null results are evidence. A study that fails to support an ICR hypothesis should be retained, analyzed, and reported with the same methodological care as a favorable study.
The Institute will not redefine an outcome after the fact to avoid a null result. Contradictory findings should trigger replication, boundary refinement, or revision.
Repeated failure of a central proposition is a reason to narrow or retire it, not to move it outside measurement.
24. Replication
Replication is not optional for mature claims. Internal replication tests whether ICR can reproduce its own result. External replication tests whether others can reproduce it without relying on the originator.
The strongest CRF claims should ultimately depend on independent evidence. A finding should not be called established solely because multiple ICR studies report it.
Replication protocols should preserve the essential intervention and measurement conditions while also testing generalizability.
25. Evidence Upgrading and Downgrading
Finding
Required action
Public-language effect
Single favorable case
Generate hypothesis
'Observed in an individual case'
Consistent case series
Plan controlled study
'Preliminary pattern'
Prospective association
Test comparison/causality
'Associated with'
Controlled favorable result
Replicate
'Produced a difference under these study conditions'
Independent replication
Increase confidence
'Supported by replicated evidence'
Mechanism directly demonstrated
Name measured pathway narrowly
'Evidence supports this measured mechanism'
Contradictory higher-quality study
Downgrade confidence
Revise public claim
Repeated replication failure
Retire or substantially narrow claim
Remove unsupported claim
26. Public Claims Must Track Evidence
ICR should maintain a claim registry linking major public claims to their evidence level, last review date, supporting sources, contradictory evidence, and approved wording.
Website pages, course materials, practitioner manuals, brochures, talks, and social media should use language consistent with the registry.
When evidence changes, public materials should be updated rather than allowing stronger legacy wording to persist.
27. Proposed ICR Claim Classes
Conceptual: 'CRF proposes...' or 'ICR hypothesizes...'
Established background: 'Research has shown...' with appropriate citation and scope.
Observed internally: 'In an ICR exploratory evaluation...' with design and sample stated.
Associated: 'X was associated with Y...' without causal wording.
Comparative: 'Participants assigned to X showed...' with comparator and uncertainty.
Replicated: 'The finding has been reproduced by independent investigators...' when true.
Not permitted without evidence: cure, treat, reverse disease, repair cells, detoxify, normalize hormones, boost immunity, restore mitochondria, or other medical/mechanistic claims unsupported by direct evidence.
28. Ethical Oversight and Human Participants
Any activity designed as systematic research involving human participants may raise ethical and regulatory requirements beyond ordinary wellness quality improvement or program evaluation. ICR should determine the appropriate level of independent ethical review before beginning projects intended to produce generalizable knowledge.
Consent should clearly distinguish wellness services, research participation, data use, photography/recording, and testimonial publication. Participation should be voluntary and withdrawal should not be penalized.
When uncertainty exists about human-subject research obligations, ICR should obtain qualified IRB, legal, or research-compliance guidance rather than self-declaring exemption.
29. Research Independence From Modality
CRF is modality-agnostic. Reiki, PEMF, light exposure, frequency-based systems, Structured Rest, exercise, psychotherapy, medication, or any other intervention does not become scientifically validated because it appears within a CRF diagram or ICR program.
Each intervention requires its own evidence. A framework study can test regulation concepts without testing every modality. A modality study can produce an outcome without validating the entire framework.
Keeping these questions separate prevents circular reasoning.
30. The ICR Validation Pipeline
1. Define the construct or intervention.
2. State the intended claim.
3. Map existing evidence and competing constructs.
4. Define measurable outcomes.
5. Establish feasibility and safety.
6. Freeze the protocol for confirmatory testing.
7. Use appropriate comparison and bias controls.
8. Analyze according to the prespecified plan.
9. Report all relevant outcomes and adverse events.
10. Compare findings with alternative explanations.
11. Replicate internally.
12. Seek independent replication.
13. Update the claim registry.
14. Revise or retire claims when evidence requires it.
31. Minimum Standard for an ICR Research Manuscript
Clear research question and evidence level.
Study design identified in title or abstract when appropriate.
Protocol/preregistration information.
Participant selection and flow.
Intervention/exposure described sufficiently for replication.
Comparator described when applicable.
Primary and secondary outcomes.
Measurement validity and timing.
Statistical methods and deviations.
Effect sizes and uncertainty.
Missing data and attrition.
Adverse events.
Limitations and competing explanations.
Conflict-of-interest disclosure.
Funding statement.
Data/code availability statement.
Appropriate reporting checklist.
32. Falsification Standard for CRF
Every major CRF proposition should eventually identify observations that would count against it. A proposition that explains every possible result is not scientifically useful.
Examples include: Regulatory Drift should be narrowed if it does not add predictive value beyond established constructs; a Coherence Index should be abandoned if it fails external validation; Structured Rest claims should narrow if appropriate controls perform equally well; and a five-layer architecture should be revised if simpler structures organize data better.
Falsification does not require one failed study to destroy a framework. It requires the framework to change rationally as the total evidence changes.
33. Version Control
All formal ICR standards, white papers, measurement instruments, protocols, and claim registries should carry a version number and date.
Substantive changes require a new version and change log. Public repository versions should remain archived rather than overwritten invisibly.
A DOI or repository record should identify the specific version being cited.
34. Governance
The Institute for Coherence and Regulation is the steward of this standard. David Fischer is the originator of CRF. Stewardship does not confer scientific authority over independent findings.
The Research and Validation Standard should be reviewed at least annually during active research development and whenever major new evidence changes a central CRF proposition.
Future governance should include external scientific review as the Institute's research program matures.
35. Ten Institutional Commitments
ICR will separate observation from inference.
ICR will distinguish exploratory from confirmatory analysis.
ICR will not hide null or unfavorable findings.
ICR will disclose relevant intellectual and commercial conflicts.
ICR will use validated measures when available.
ICR will not infer mechanisms that were not measured.
ICR will match public wording to evidence level.
ICR will seek independent replication for mature claims.
ICR will revise concepts that fail meaningful tests.
ICR will preserve the distinction between wellness support and medical diagnosis or treatment.
Harmonized Role of WP-010
WP-010 is the methodological bridge between the conceptual Coherence & Regulation Framework and empirical research. It explains how a CRF proposition becomes an operational research question, a measurable variable, a study design, and an interpretable result. It is not the Institute-wide governance standard. That function belongs to WP-024, A Methodological Bridge From Conceptual Framework to Testable Evidence.
Formal Boundary Between WP-010 and WP-024
WP-010 answers: How do we translate a CRF concept into a testable study? WP-024 answers: What rules must ICR research follow before evidence is promoted, published, generalized, or used to support institutional claims? WP-010 is methodological architecture; WP-024 is governance, evidence control, reporting discipline, and institutional accountability.
Canonical Framework-to-Evidence Chain
CRF research should proceed through the following chain: Conceptual Claim → Construct → Operational Definition → Falsifiable Hypothesis → Observable Implication → Variable → Instrument or Method → Sampling and Timing Plan → Study Design → Quality Control → Analysis Plan → Result → Alternative Explanations → Evidence-Level Assignment → Claim Language.
Start With the Claim, Not the Device
Research should begin with the proposition to be tested, not with an available device, modality, biomarker, questionnaire, or preferred outcome. Instruments are selected only after the construct, observable implication, population, context, and intended inference are defined.
Construct Specification
Every study should state what construct is being investigated, what it is not, the relevant CRF layer or dynamic construct, the population and context, the time scale, and the type of inference sought. Terms such as coherence, reserve, drift, flexibility, recovery, compensation, and adaptive capacity should not be used as interchangeable labels.
Operational Definition
An operational definition states how the construct will be represented in a particular study. It must be specific enough that another research team could determine whether the same construct was measured in the same way. Operationalization does not prove that the measure captures the full construct.
Falsifiable Hypotheses
A useful hypothesis identifies what should be observed if the proposition is supported and what pattern would weaken it. Direction, timing, comparison, population, and outcome should be prespecified where feasible. Post-hoc observations may generate hypotheses but should not be presented as confirmatory tests.
Measurement Selection
Measures should be selected for validity, reliability, measurement error, responsiveness, interpretability, feasibility, and fit to the intended use. Established measurement-science standards should be used where applicable rather than creating parallel ICR rules. For patient-reported measures, COSMIN provides a mature framework for evaluating measurement properties and reporting.
Dynamic Constructs Require Dynamic Designs
CRF constructs such as recovery, reserve, flexibility, timing, compensation, and adaptive capacity often cannot be adequately tested with one resting measurement. When the hypothesis concerns response to demand, the study should ordinarily include a defined challenge or naturally occurring demand, response measurement, a recovery period, and where relevant a second challenge.
Matched-Demand Principle
Comparisons of regulatory cost, compensation, efficiency, recovery, reserve, or adaptation are strongest when the demand is defined and sufficiently comparable across observations. Changing demand can create the appearance of improvement or deterioration even when underlying capability is unchanged.
Comparator Logic
The comparator should match the causal or descriptive question. Depending on the study, this may be baseline, usual activity, wait-list, attention control, active comparator, matched low-demand condition, standard care, another intervention, or repeated within-person observation. No comparator is universally appropriate.
Feasibility Before Efficacy
Novel CRF measures and protocols should normally begin with feasibility and descriptive work. Feasibility studies can determine recruitment, adherence, missingness, measurement burden, protocol tolerance, timing, data quality, and safety. They should not be relabeled as efficacy trials after favorable results appear.
Exploratory Versus Confirmatory Work
Exploratory analyses identify patterns and generate hypotheses. Confirmatory analyses test prespecified hypotheses using a locked or clearly documented analysis plan. Both are legitimate, but they answer different questions and should be labeled accordingly.
Alternative Explanations
Every interpretation should consider plausible alternatives such as regression to the mean, natural history, expectancy, attention, learning, fatigue, device error, measurement error, changing demand, sleep, medication, illness, training status, environmental changes, and concurrent care.
Modality Firewall
Evidence for a CRF construct does not establish efficacy or mechanism for Reiki, PEMF, frequency-based approaches, scalar approaches, red-light exposure, structured rest, or any other modality. Conversely, evidence for a modality does not validate the entire CRF. Each claim requires its own evidentiary chain.
Evidence Assignment
After analysis, findings should be assigned to the ICR evidence ladder based on the design actually completed and the strength of reproducible evidence, not on the ambition of the original hypothesis. The mature 0-6 evidence ladder is governed by WP-024.
Null, Negative, and Inconclusive Findings
A result that fails to support the hypothesis is part of the evidence architecture. Null, negative, contradictory, and inconclusive findings should be retained, reported, and used to revise constructs, measures, or predictions rather than being excluded from the ICR knowledge base.
Replication and Generalization
A finding in one sample, setting, practitioner, device, or protocol should not be generalized automatically. External validation and independent replication become increasingly important as claims move toward institutional, healthcare-facing, or public recommendations.
Measurement Development Is a Separate Research Program
When ICR creates a new questionnaire, profile, score, or index, validation of that instrument is itself a research program. A measure should not be treated as validated merely because it produces stable-looking numbers or correlates with another favored variable. WP-009 and WP-023 govern the measurement architecture.
Relationship to the Current Coherence Reset Evaluation
The current Coherence Reset participant evaluation is best treated as preliminary program evaluation and hypothesis generation. It can examine feasibility, participant-reported trajectories, adherence, acceptability, and candidate outcomes. Without appropriate controls, validated instruments, prespecified inferential methods, and sufficient sample size, it should not be used to claim efficacy, mechanism, or clinical effectiveness.
Publication Transition Rule
Before a CRF study is described as confirmatory or used to support a stronger public claim, the protocol, primary outcomes, analysis plan, comparator logic, measurement properties, safety procedures, and evidence-level criteria should be documented in advance. WP-024 supplies the formal governance requirements for this transition.
Incremental-Value Requirement
CRF research should test whether its constructs or architectures add useful information beyond established concepts and simpler models. If an established construct predicts or explains the outcome equally well with fewer assumptions, the CRF construct should be narrowed, merged, revised, or retired.
Canonical Public Definition
WP-010 is ICR's framework-to-evidence methodology: it explains how a CRF idea is converted into a defined construct, falsifiable hypothesis, measurable study, and appropriately limited conclusion. WP-024 separately governs the standards ICR must satisfy before evidence is promoted or institutional claims are strengthened.
36. Conclusion
A framework becomes scientifically credible not when it accumulates terminology, but when it establishes rules that can prove its own claims wrong. A Methodological Bridge From Conceptual Framework to Testable Evidence provides those rules.
The standard allows early case studies and wellness evaluations to contribute useful information while preventing them from being mistaken for proof. It creates a path from conceptual formulation through feasibility, association, comparison, mechanism testing, replication, and synthesis.
Most importantly, it binds ICR's public claims to the evidence rather than asking the evidence to conform to ICR's claims. That principle should govern the Institute's research, education, publications, and future development.
Declarations
Author and originator: David Fischer. Institutional affiliation: Institute for Coherence and Regulation (ICR), Knightdale, North Carolina, USA.
Competing interests: The author has intellectual and commercial interests in CRF, ICR educational programs, certifications, publications, and wellness services. These interests should be disclosed in future research outputs.
Ethics: This governance white paper reports no human-subject research. Data availability: No dataset was generated.
Canonical designation: ICR-WP-010, Publication Version 1.0, September 2026.
References and Standards
National Institutes of Health. Enhancing Reproducibility through Rigor and Transparency. NIH Grants & Funding. Current policy/resource page accessed September 2026.
EQUATOR Network. Reporting Guidelines Library. Enhancing the QUAlity and Transparency Of health Research. Current resource accessed September 2026.
Hopewell, S., Chan, A.-W., Collins, G. S., et al. (2025). CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ, 389, e081123. https://doi.org/10.1136/bmj-2024-081123
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P.; STROBE Initiative. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Medicine, 4(10), e296. https://doi.org/10.1371/journal.pmed.0040296
Gagnier, J. J., Kienle, G., Altman, D. G., Moher, D., Sox, H., & Riley, D.; CARE Group. (2014). The CARE guidelines: Consensus-based clinical case report guideline development. Journal of Clinical Epidemiology, 67(1), 46-51. https://doi.org/10.1016/j.jclinepi.2013.08.003
PRISMA Group. PRISMA 2020 Statement: updated guideline for reporting systematic reviews. BMJ, 2021;372:n71. https://doi.org/10.1136/bmj.n71
Chan, A.-W., Boutron, I., Hopewell, S., et al. (2025). SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ, 389, e081477. https://doi.org/10.1136/bmj-2024-081477
Prinsen, C. A. C., Mokkink, L. B., Bouter, L. M., Alonso, J., Patrick, D. L., de Vet, H. C. W., & Terwee, C. B. (2018). COSMIN guideline for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27, 1147-1157. https://doi.org/10.1007/s11136-018-1798-3
Munafò, M. R., et al. (2017). A manifesto for reproducible science. Nature Human Behaviour, 1, 0021. https://doi.org/10.1038/s41562-016-0021
Nosek, B. A., et al. (2015). Promoting an open research culture. Science, 348(6242), 1422–1425. https://doi.org/10.1126/science.aab2374
Appendix A — ICR Evidence Review Form
Claim under review:
Current approved wording:
Current evidence level:
Evidence quality:
Supporting studies:
Contradictory/null studies:
Population/intervention boundaries:
Mechanism directly measured? Yes/No:
Independent replication? Yes/No:
Known harms/adverse events:
Conflicts of interest:
Recommended evidence level after review:
Recommended public wording:
Research needed next:
Reviewer/date/version:
Appendix B — Study Classification Decision Rule
If the primary purpose is to document feasibility or individual experience, classify the work as Level 1. If the study estimates relationships without assigned comparison, classify it as Level 2. If it prospectively compares defined conditions, it may qualify as Level 3 depending on design quality. If it directly validates a construct or mechanism, it may contribute Level 4 evidence. Independent reproduction contributes Level 5. Convergent synthesis across multiple high-quality independent studies may support Level 6.
A study may contribute to more than one question at different levels. The highest level should never be assigned merely because advanced equipment or statistical methods were used.
Appendix C — Canonical Public Statement
ICR uses a staged evidence standard. Concepts begin as hypotheses; case studies generate signals; observational research tests associations; controlled studies test comparative effects; mechanism and measurement studies test how constructs operate; and independent replication is required for mature claims. Public language is revised as evidence strengthens, weakens, or changes.